Literature DB >> 15237707

Analysis of cytotoxic T lymphocyte antigen-4 (CTLA-4) exon 1 polymorphism in patients with type 1 diabetes mellitus in a Turkish population.

Sermin Genc1, Kursad Genc, Ogun Sercan, Sefa Kizildag, Zeynep Gulay, Tuba Atay, Bumin Dundar, Meral Sakizli, Atilla Büyükgebiz.   

Abstract

Recent studies have described linkage and association between cytotoxic T-lymphocyte antigen-4 (CTLA-4) gene polymorphism and type 1 diabetes mellitus (DM1) in some ethnic populations, but not others. This finding suggests that CTLA-4 gene association with DM1 may be influenced by the racial composition of the population. Thus, it is important to study the polymorphism of the CTLA-4 gene in different ethnic groups. In this case-control association study, the CTLA-4 gene exon 1 A/G polymorphism was analyzed in 48 children with DM1 and 80 healthy controls using polymerase chain reaction-restriction fragment length polymorphism analysis. The possible interaction of the CTLA-4 gene polymorphism with the presence of established genetic markers (HLA-DR genotyping) was also evaluated in 29 patients. The results of the present study do not suggest an association of the known polymorphism in exon 1 of the CTLA-4 gene with DM1 in this Turkish population, and G-allele containing CTLA-4 genotypes were not preferentially associated with age at clinical presentation or with presence of other genetic (HLA-DR3 or -DR4) markers of DM1.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15237707     DOI: 10.1515/jpem.2004.17.5.731

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN: 0334-018X            Impact factor:   1.634


  1 in total

Review 1.  Cytotoxic T-lymphocyte-associated protein 4 +49A/G polymorphisms contribute to the risk of type 1 diabetes in children: An updated systematic review and meta-analysis with trial sequential analysis.

Authors:  Bo Wang; Wei Du; Yutao Jia; Xiaobai Zhang; Guorui Ma
Journal:  Oncotarget       Date:  2017-02-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.